Urinary Tract Infection Testing Market to Grow with a CAGR of 4.25% through 2028
Rising urinary tract infections incidence rates and growing private
and public sector investments are factors driving the Global Urinary Tract
Infection Testing Market in the forecast period 2024-2028.
According to TechSci Research report, “Urinary
Tract Infection Testing Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Urinary
Tract Infection Testing Market stood at USD 561.32 million in 2022 and is
anticipated to grow with a CAGR of 4.25% in the forecast period, 2024-2028. Urinary Tract Infections (UTIs) are a common medical concern affecting
millions of people worldwide. These infections, which primarily impact the
urinary system, can cause discomfort, pain, and even lead to more severe
complications if left untreated. As a result, the global market for urinary
tract infection testing has witnessed significant growth over the years.
A Urinary
Tract Infection is an infection that can occur in any part of the urinary
system, including the bladder, urethra, ureters, and kidneys. Common symptoms
of UTIs include frequent urination, burning sensation, and cloudy, bloody, or
strong-smelling urine. These infections can affect people of all ages and
genders, but women are more susceptible due to their shorter urethra, which
allows bacteria easier access to the urinary tract.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Urinary Tract Infection Testing Market”
The foremost driver of the global UTI
testing market is the increasing prevalence of urinary tract infections. A
growing population, aging demographic, and lifestyle factors contribute to
higher UTI rates. As the number of UTI cases continues to rise, the demand for
effective and rapid testing methods also increases. The healthcare industry has
witnessed significant advancements in diagnostic technologies. This includes
the development of more accurate and efficient UTI testing methods. The
availability of point-of-care tests and molecular diagnostics has improved
diagnostic accuracy, allowing for faster and more reliable results.
There is a heightened awareness of UTIs
among the general population, thanks to healthcare campaigns, educational
initiatives, and increased public awareness. Patients are now more proactive in
seeking medical care for UTIs, leading to early diagnosis and treatment. The
rise of antibiotic resistance is a growing global health concern. As more UTIs
become resistant to common antibiotics, accurate diagnostic tests are essential
to determine the most appropriate and effective treatment. This factor encourages
the demand for UTI testing methods that guide clinicians in prescribing the
right antibiotics.
The Global Urinary Tract Infection Testing Market is
segmented into type, end use and company.
Based on end use, the reference laboratories segment
has emerged as the predominant market leader. Many reference laboratories invest
in ongoing research and development efforts. This allows them to stay at the
forefront of diagnostic technology and continually improve their testing
methods. Such innovation is crucial for identifying emerging UTI strains and
improving treatment strategies. Reference laboratories often have seamless integration
with electronic health record (EHR) systems, making it easy for healthcare
providers to access and share patient data, fostering a collaborative approach
to patient care.
Based on region, North America segment is expected to
grow during the forecast period. Technological advancements in the
field of medical diagnostics have been instrumental in the growth of the UTI
testing market. North America has been a hub for innovation and research in
this area, leading to the development of highly accurate and efficient UTI
testing methods. These innovations make testing more accessible and reliable
for patients, thus driving the market's growth.
The Asia Pacific region is experiencing rapid market
growth. Health awareness and education campaigns in Asia Pacific have
contributed to increased understanding of UTIs and the importance of early
detection. Patients and healthcare professionals alike are better informed
about the symptoms, risks, and consequences of UTIs, which has led to a higher
rate of testing and diagnosis. Public awareness campaigns have been
instrumental in fostering a proactive approach to UTI management.
Major companies operating in Global Urinary Tract
Infection Testing Market are:
- QIAGEN NV
- Accelerate Diagnostics, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Siemens Healthcare GmbH
- Randox Laboratories Ltd.
- Thermo Fisher Scientific, Inc.
- BIOMÉRIEUX
- T2 Biosystems, Inc
Download Free Sample Report
Customers can also request for 10% free customization
on this report
“The Global Urinary Tract Infection Testing Market is
experiencing remarkable growth due to various market drivers. Factors such as
the rising incidence of UTIs, technological advancements, increased awareness,
antibiotic resistance concerns, telemedicine services, regulatory support, and
global market expansion all play pivotal roles in driving the market forward.
As healthcare continues to evolve, the demand for effective and efficient UTI
testing methods is expected to persist, offering growth prospects for
manufacturers and healthcare providers alike.,” said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based management consulting firm.
“Global Urinary Tract Infection Testing Market By Type (Urethritis,
Cystitis, Pyelonephritis), By End use (General Practitioners (GPs), Urologists,
Urogynecologists, Hospital Laboratories, Reference Laboratories, Others), By
Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Urinary Tract Infection Testing Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Urinary Tract Infection Testing Market.
Contact Us-
TechSci Research LLC
420 Lexington Avenue, Suite
300,
New York, United States-
10170
M: +13322586602
Email: [email protected]
Website: www.techsciresearch.com